Insider Transactions in Q4 2023 at Brickell Biotech, Inc. (BBI)
Insider Transaction List (Q4 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 20
2023
|
Exploration Capital, LLC |
BUY
Open market or private purchase
|
Direct |
47,000
+50.0%
|
$0
$0.84 P/Share
|
|
Dec 08
2023
|
Aaron Fox Colis VP of Finance & CAO |
SELL
Open market or private sale
|
Direct |
74
-100.0%
|
$0
$0.91 P/Share
|
|
Dec 06
2023
|
Exploration Capital Fund, LP |
SELL
Open market or private purchase
|
Direct |
17,233
-2.4%
|
$0
$0.9 P/Share
|
|
Dec 05
2023
|
Exploration Capital Fund, LP |
SELL
Open market or private purchase
|
Direct |
5,188
-0.75%
|
$0
$0.85 P/Share
|
|
Dec 04
2023
|
Exploration Capital Fund, LP |
SELL
Open market or private purchase
|
Direct |
7,579
-1.11%
|
$0
$0.85 P/Share
|
|
Dec 04
2023
|
Aaron Fox Colis VP of Finance & CAO |
SELL
Open market or private sale
|
Direct |
36
-32.73%
|
$0
$0.85 P/Share
|
|
Oct 02
2023
|
David R. Mc Avoy Gen Counsel, CCO, & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
7,358
-31.42%
|
$0
$0.98 P/Share
|
|
Oct 02
2023
|
David R. Mc Avoy Gen Counsel, CCO, & Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+46.06%
|
-
|
|
Oct 02
2023
|
Andrew D Sklawer President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
20,833
-34.66%
|
$0
$0.98 P/Share
|
|
Oct 02
2023
|
Andrew D Sklawer President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
55,000
+47.78%
|
-
|